Merck (MRK, $37.14) has always been a tough stock to trade. It’s an investment in the Drug sector which carries extra risk due to the nature of their business. Drug and Biotech stocks trade on product announcements and development of their pipeline. Once different drugs are announced or “created” andRead more

More